• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

优先考虑公共卫生因素来定义劣质药品。

The primacy of public health considerations in defining poor quality medicines.

机构信息

Wellcome Trust-Mahosot Hospital-Oxford Tropical Medicine Research Collaboration, Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR.

出版信息

PLoS Med. 2011 Dec;8(12):e1001139. doi: 10.1371/journal.pmed.1001139. Epub 2011 Dec 6.

DOI:10.1371/journal.pmed.1001139
PMID:22162953
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3232210/
Abstract

Paul Newton and colleagues argue that public health, and not intellectual property or trade issues, should be the prime consideration in defining and combating counterfeit medicines, and that the World Health Organization (WHO) should take a more prominent role.

摘要

保罗·牛顿（Paul Newton）等人认为，在界定和打击假药时，应主要考虑公共卫生问题，而不是知识产权或贸易问题，世界卫生组织（WHO）应发挥更突出的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3b/3232210/16efdfc49e01/pmed.1001139.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3b/3232210/16efdfc49e01/pmed.1001139.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3b/3232210/16efdfc49e01/pmed.1001139.g001.jpg

相似文献

1
The primacy of public health considerations in defining poor quality medicines.优先考虑公共卫生因素来定义劣质药品。
PLoS Med. 2011 Dec;8(12):e1001139. doi: 10.1371/journal.pmed.1001139. Epub 2011 Dec 6.
2
Impact of poor-quality medicines in the 'developing' world.劣质药品对“发展中”世界的影响。
Trends Pharmacol Sci. 2010 Mar;31(3):99-101. doi: 10.1016/j.tips.2009.11.005. Epub 2010 Feb 1.
3
Combatting substandard and falsified medicines: a view from Rwanda.打击劣药和假药：来自卢旺达的观点。
PLoS Med. 2013;10(7):e1001476. doi: 10.1371/journal.pmed.1001476. Epub 2013 Jul 2.
4
The joint interagency task force and the global steering committee for the quality assurance of health products: two new and proactive approaches promoting access to safe and effective medicines.卫生产品质量保证联合跨部门特别工作组和全球指导委员会：促进获取安全有效药物的两种新的积极方法。
Am J Trop Med Hyg. 2015 Jun;92(6 Suppl):133-136. doi: 10.4269/ajtmh.15-0208.
5
The Medicines Quality Database: a free public resource.药品质量数据库：一个免费的公共资源。
Bull World Health Organ. 2014 Jan 1;92(1):2-2A. doi: 10.2471/BLT.13.130526.
6
Counterfeit drugs: an Australian perspective.假药：澳大利亚视角
Med J Aust. 2016 May 16;204(9):344. doi: 10.5694/mja16.00105.
7
Counterfeiting and piracy of pharmaceuticals.药品的假冒和盗版。
IEEE Eng Med Biol Mag. 2008 Nov-Dec;27(6):66-9. doi: 10.1109/MEMB.2008.929891.
8
Stemming the global trade in falsified and substandard medicines.遏制全球假药和劣药贸易。
JAMA. 2013 Apr 24;309(16):1693-4. doi: 10.1001/jama.2013.3048.
9
[Counterfeit and Falsified Drugs: an Overview].[假冒伪劣药品概述]
Therapie. 2015 Sep-Oct;70(5):455-64. doi: 10.2515/therapie/2015031. Epub 2015 Jun 12.
10
Promoting public health and protecting consumers in a global economy: an overview of HHS/FDA's international activities.在全球经济中促进公众健康与保护消费者：美国卫生与公众服务部/食品药品监督管理局国际活动概述
Food Drug Law J. 2005;60(3):339-46.

引用本文的文献

1
Quality of antiretroviral, antimalarial and antituberculosis medicines in Zambia: Findings of routine post-marketing surveillance.赞比亚抗逆转录病毒药物、抗疟疾药物和抗结核药物的质量：上市后常规监测结果
J Med Access. 2024 Jul 25;8:27550834241266755. doi: 10.1177/27550834241266755. eCollection 2024 Jan-Dec.
2
The Global Landscape on the Access to Cancer Medicines for Breast Cancer: The ONCOLLEGE Experience.全球乳腺癌癌症药物获取状况：ONCOLLEGE 经验。
Cancer Treat Res. 2023;188:353-368. doi: 10.1007/978-3-031-33602-7_14.
3
Estimating the prevalence of poor-quality anti-TB medicines: a neglected risk for global TB control and resistance.

本文引用的文献

1
Beef up international cooperation on counterfeits.加强打击假冒伪劣商品的国际合作。
Nat Med. 2010 Apr;16(4):366. doi: 10.1038/nm0410-366.
2
Impact of poor-quality medicines in the 'developing' world.劣质药品对“发展中”世界的影响。
Trends Pharmacol Sci. 2010 Mar;31(3):99-101. doi: 10.1016/j.tips.2009.11.005. Epub 2010 Feb 1.
3
Substandard medicines in resource-poor settings: a problem that can no longer be ignored.资源匮乏地区的劣质药品：一个不容忽视的问题。
估算劣质抗结核药物的流行情况：全球结核病控制和耐药性面临的一个被忽视的风险。
BMJ Glob Health. 2023 Jul;8(7). doi: 10.1136/bmjgh-2023-012039.
4
Assessment of the Antimalarial Treatment Failure in Ebonyi State, Southeast Nigeria.尼日利亚东南部埃邦伊州抗疟治疗失败情况评估
J Xenobiot. 2023 Jan 3;13(1):16-26. doi: 10.3390/jox13010003.
5
Developing and implementing National Health Insurance: learnings from the first try in Benin.发展和实施国家健康保险：贝宁首次尝试的经验教训。
BMJ Glob Health. 2022 Nov;7(11). doi: 10.1136/bmjgh-2022-009027.
6
Detecting falsified oral contraceptives by visual assessment and diffuse reflectance spectroscopy (350-2500 nm): the need for supplementing traditional pharmacopeia techniques and the public health implications.通过视觉评估和漫反射光谱法（350 - 2500纳米）检测伪造口服避孕药：补充传统药典技术的必要性及对公共卫生的影响
Heliyon. 2022 Oct 1;8(10):e10837. doi: 10.1016/j.heliyon.2022.e10837. eCollection 2022 Oct.
7
Patient safety and public health concerns: poor dissolution rate of pioglitazone tablets obtained from China, Myanmar and internet sites.患者安全和公共卫生问题：从中国、缅甸和互联网购得的吡格列酮片溶解率差。
BMC Pharmacol Toxicol. 2021 Mar 2;22(1):12. doi: 10.1186/s40360-021-00478-x.
8
Quality assurance systems of pharmaceutical distributors in low-income and middle-income countries: weaknesses and ways forward.中低收入国家药品分销商的质量保证体系：弱点与前进方向。
BMJ Glob Health. 2020 Oct;5(10). doi: 10.1136/bmjgh-2020-003147.
9
Antibiotic Resistance: Moving From Individual Health Norms to Social Norms in One Health and Global Health.抗生素耐药性：在“同一健康”和全球健康背景下从个体健康规范迈向社会规范
Front Microbiol. 2020 Aug 28;11:1914. doi: 10.3389/fmicb.2020.01914. eCollection 2020.
10
A survey of nongovernmental organizations on their use of WHO's prequalification programme.非政府组织使用世卫组织资格预审规划情况调查。
Bull World Health Organ. 2020 Jun 1;98(6):413-419. doi: 10.2471/BLT.19.233882. Epub 2020 Apr 7.
Trop Med Int Health. 2008 Aug;13(8):1062-72. doi: 10.1111/j.1365-3156.2008.02106.x. Epub 2008 Jul 8.
4
Counterfeit anti-infective drugs.假冒抗感染药物。
Lancet Infect Dis. 2006 Sep;6(9):602-13. doi: 10.1016/S1473-3099(06)70581-3.
5
Counterfeit and substandard antimalarial drugs in Cambodia.柬埔寨的假冒伪劣抗疟药物。
Trans R Soc Trop Med Hyg. 2006 Nov;100(11):1019-24. doi: 10.1016/j.trstmh.2006.01.003. Epub 2006 Jun 12.
6
Manslaughter by fake artesunate in Asia--will Africa be next?亚洲假药青蒿琥酯致人死亡——非洲会步其后尘吗？
PLoS Med. 2006 Jun;3(6):e197. doi: 10.1371/journal.pmed.0030197.